Peripheral blood stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia [1]

Stem Cells and Development

Volumn 14, Issue 1, 2005, Pages 3-5

  Nichols, Gwen L ^a   Skerrett, Donna L ^b  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE; MONOCLONAL ANTIBODY; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CD34 SELECTION; CELL SELECTION; CELL SEPARATION; CHRONIC LYMPHATIC LEUKEMIA; COMBINATION CHEMOTHERAPY; FOLLICULAR LYMPHOMA; HUMAN; LETTER; LYMPHOMA; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REMISSION; STEM CELL HARVESTING; STEM CELL MOBILIZATION; WALDENSTROEM MACROGLOBULINEMIA;

EID: 14744274755     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2005.14.3     Document Type: Letter

References (10)

1. Micallef IN, J Apostolidis, AZ Rohatiner, C Wiggins, CR Crawley, JM Foran, M Leonhardt, M Bradburn, E Okukenu, A Salam, J Matthews, JD Cavenagh, RK Gupta and TA Lister (2000). Factors which predict unsuccessful mobilization of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematol J 1:367-373.
2. Ketterer N, G Salles, I Moullet, C Dumontet, A EIJaafari-Corbin, P Tremisi, C Thieblemont, B Durand, EM Neidhardt-Berard, H Samaha, D Rigal and B Coiffier. (1998). Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 103:235-242.
3. Seymour JF, AP Grigg, J Szer and RM Fox. (2001). Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lympoproliferative disorders. Ann Oncol 12:1455-1460.
4. Montillo M, AM Cafro, A Tedeschi, B Brando, P Oreste, S Veronese, V Rossi, R Cairoli, E Pungolino and E Morra. (2002). Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine. Haematologica 87:695-700; discussion 700.
5. Mauro FR, R Foa, G Meloni, M Gentile, E Giammartini, D Giannarelli, MS De Propris, MC Rapanotti, P de Fabritiis and F Mandelli. (2002). Fludarabine, ara-C, novatrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients. Haematologica 87:926-933.
6. Bosch F, A Ferrer, A Lopez-Guillermo, E Gine, B Bellosillo, N Villamor, D Colomer, F Cobo, M Perales, J Esteve, A Altes, J Besalduch, J Ribera and E Montserrat for the GELCAB (Grup per l'Estudi dels Limfomes a Catalunya i Balears). (2002). Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia. Br J Haematol 119:9976-9984.
7. Laszlo D, P Galieni, D Raspadori, M Tozzi, F Lauria and G Martinelli. (2000). Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non-Hodgkin's lymphoma patients. Leuk Lymphoma 37:157-161.
8. Michallet M, A Thiebaut, P Dreger, K Remes, N Milpied, G Santini, M Hamon, B Bjorkstrand, E Kimby, A Belhabri, ML Tanguy and JF Apperley. (2000). Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP). Br J Haematol 108:595-601.
9. Itala M, TT Pelliniemi, A Rajamaki and K Remes. (1997). Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield. Bone Marrow Transplant 19:647-651.
10. Savage DG, NS Cohen, CS Hesdorffer, D Heitjan, MW Oster, TJ Garrett, M Bar, S del Prete, R March, M Lonberg, S Talbot, JG Mears, M Flamm, RN Taub and G Nichols. (2003). Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia. Leuk Lymphoma 44:477-481.